+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Needle Free Drug Delivery Devices Market 2019-2025

  • PDF Icon


  • November 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4871644
UP TO OFF until Dec 31st 2022
Global Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report, By Technology (Inhaler Technology, Jet Injectors, Transdermal Patch Technology, and Others), By Application (Vaccines Delivery, Pain Management, Insulin Delivery, Pediatric Injections, and Others), and Forecast 2019-2025.

The global needle-free drug delivery devices market is expected to grow at a significant rate during the forecast period 2019-2025. The increasing need for self-administration of drugs as in the case of diseases such as diabetes and benefits offered by this technology such as pain-free drug delivery has enhanced the size of needle-free drug delivery devices industry. Further, the increasing focus on the growth of portable delivery devices has a positive and high impact on the growth of the global needle-free drug delivery devices market across the globe.

The global needle-free drug delivery devices market is segmented on the basis of technology and application. Based on the technology, the market is segmented into inhaler technology, jet injectors, transdermal patch technology, others. Jet injectors are used for a broad range of applications due to their benefits such as rapid administration, faster response rates, and improved dosing accuracy. In addition, these devices offer better diffusion into tissues and are easily portable. Further, on the basis of application, the market is segmented into pain management, insulin delivery, vaccine delivery, pediatric injections, and others.

Geographically, the market report covers the analysis of four major regions; North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific, and Rest of the World (RoW). North America is expected to hold a considerable share, while Asia-Pacific is expected to show remarkable growth during the forecast period. Further, the report covers the analysis of several players operating in the market. Some of the key players operating in the market include Antares Pharma, Inc., 3M Co., Valeritas Inc., Endo International PLC, Injex Pharma AG, Pharmajet Inc., Inovio Pharmaceuticals, Inc., and Penjet Corp.

Research Methodology

The market study of the global needle-free drug delivery devices market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, investing companies and venture capitalists, hospitals and clinics, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:
1. Global Needle-Free Drug Delivery Devices Market Research and Analysis by Technology
2. Global Needle-Free Drug Delivery Devices Market Research and Analysis by Application

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. 3M Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Ferring Holdings SA Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Endo international PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Valeritas, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Needle-Free Drug Delivery Devices Market by Technology
5.1.1. Inhaler Technology
5.1.2. Jet Injectors
5.1.3. Transdermal Patch Technology
5.1.4. Other Technologies (Laser-Based Technology)
5.2. Global Needle-Free Drug Delivery Devices Market by Application
5.2.1. Pain Management
5.2.2. Insulin Delivery
5.2.3. Vaccine delivery
5.2.4. Pediatric Injections
5.2.5. Others
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3M Co.
7.2. Akra Dermojet
7.3. Bespak
7.4. Boerhinger Ingelheim International GmbH
7.5. Crossject
7.6. Enesi Pharma Ltd.
7.7. Ferring Holding SA (Antares Pharma, Inc.)
7.8. GlaxoSmithKline PLC
7.9. Injex Pharma GmbH
7.10. Inovio Pharmaceuticals, Inc.
7.11. Mika Medical Co.
7.12. Novartis AG
7.13. Penjet Corp.
7.14. PharmaJet, Inc.
7.15. Portal Instruments
7.16. ProSolus, Inc.
7.17. Pulse NeedleFree Systems
7.18. Spirit Healthcare Ltd.
7.19. Valeritas, Inc

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M Co.
  • Akra Dermojet
  • Bespak
  • Boerhinger Ingelheim International GmbH
  • Crossject
  • Enesi Pharma Ltd.
  • Ferring Holding SA (Antares Pharma, Inc.)
  • GlaxoSmithKline PLC
  • Injex Pharma GmbH
  • Inovio Pharmaceuticals, Inc.
  • Mika Medical Co.
  • Novartis AG
  • Penjet Corp.
  • PharmaJet, Inc.
  • Portal Instruments
  • ProSolus, Inc.
  • Pulse NeedleFree Systems
  • Spirit Healthcare Ltd.
  • Valeritas, Inc